|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expense | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Other income, net | |||||
| Interest expense | |||||
| Total other (expense) income, net | |||||
| Loss before income taxes | |||||
| Income tax provision | |||||
| Net loss | |||||
| Other comprehensive gain: | |||||
| Foreign currency adjustments | |||||
| Actuarial gain on defined benefit plan | |||||
| Unrealized loss on deferred compensation trust assets | |||||
| Total other comprehensive gain | |||||
| Comprehensive loss | |||||
| Net loss per share: | |||||
| Basic net loss per share (in dollars per share) | |||||
| Diluted net loss per share (in dollars per share) | |||||
| Weighted-average common shares outstanding: | |||||
| Shares used in computation of basic net loss per share (in shares) | |||||
| Shares used in computation of diluted net (loss) income per share (in shares) |
Loading...
